Summit Financial Group’s Elevance Health ELV Stock Holding History

Summit Financial Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$337K	Hold	649	–	–	0.12%	148
2023 Q4	$306K	Sell	649 -39	-6%	-$18K	0.12%	150
2023 Q3	$300K	Hold	688	–	–	0.13%	147
2023 Q2	$306K	Hold	688	–	–	0.12%	151
2023 Q1	$316K	Hold	688	–	–	0.12%	154
2022 Q4	$353K	Sell	688 -51	-7%	-$25.9K	0.14%	147
2022 Q3	$336K	Sell	739 -5	-0.7%	-$2.39K	0.14%	144
2022 Q2	$359K	Hold	744	–	–	0.14%	144
2022 Q1	$365K	Hold	744	–	–	0.12%	148
2021 Q4	$345K	Buy	744 +51	+7%	+$21.5K	0.11%	158
2021 Q3	$258K	Hold	693	–	–	0.09%	184
2021 Q2	$265K	Hold	693	–	–	0.1%	173
2021 Q1	$249K	Sell	693 -53	-7%	-$17K	0.1%	167
2020 Q4	$240K	Sell	746 -24	-3%	-$7.37K	0.11%	151
2020 Q3	$207K	Hold	770	–	–	0.1%	148
2020 Q2	$202K	Buy	+770	New	+$205K	0.11%	151
2020 Q1	–	Sell	-783	Closed	-$236K	–	147
2019 Q4	$236K	Buy	+783	New	+$215K	0.11%	145

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Summit Financial Group's ELV Position: Q1 2024 in Review

Summit Financial Group held its Elevance Health (ELV) position steady in Q1 2024 at 649 shares worth $337K. The position accounts for 0.12% of the portfolio, ranked #148.

Summit Financial Group first reported a position in ELV in Q4 2019 and has held it in 17 quarters since. The position peaked at $365K in Q1 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Summit Financial Group held 649 shares of Elevance Health worth $337K as of Q1 2024.
Summit Financial Group left its Elevance Health share count unchanged in Q1 2024.
Elevance Health made up 0.12% of Summit Financial Group's portfolio in Q1 2024, its #148 holding.
Summit Financial Group first reported a position in Elevance Health in Q4 2019 and has held it in 17 quarters since.
Summit Financial Group's Elevance Health position peaked at $365K in Q1 2022.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.